Literature DB >> 19325564

Is a reduced estimated glomerular filtration rate a risk factor for stroke in patients with type 2 diabetes?

Ryotaro Bouchi1, Tetsuya Babazono, Izumi Nyumura, Kiwako Toya, Toshihide Hayashi, Mari Ohta, Ko Hanai, Yuka Kiuchi, Kumi Suzuki, Yasuhiko Iwamoto.   

Abstract

Although chronic kidney disease is a risk factor for cardiovascular disease it is unclear whether diabetic patients with a reduced glomerular filtration rate (GFR), independent of (micro)albuminuria, carry an increased risk of stroke. We therefore investigated the independent effect of estimated GFR (eGFR) on stroke events in patients with type 2 diabetes mellitus (T2DM). We studied T2DM patients with an eGFR >or=15 ml min(-1) per 1.73 m(2), who had no history of stroke. Patients were divided into four categories by the eGFR at baseline for comparison: >or=90, 60-89, 30-59 and 15-29 ml min(-1) per 1.73 m(2). The end point was an incident stroke event. The Cox proportional hazard model was used to calculate the hazard ratio (HR) and 95% confidence interval (CI). The study included a total of 1300 T2DM patients (546 women and 754 men) with a mean (+/-s.d.) age of 63+/-13 years. During a mean follow-up period of 3.7+/-1.4 years, 91 patients experienced an incident stroke event. Although a lower eGFR was associated with an increased stroke risk using a univariate model, statistical significance disappeared after adjusting for other risk factors including albuminuria. The HR (95% CI) was 0.75 (0.40-1.41, P=0.373), 0.99 (0.50-1.95, P=0.964) and 0.91 (0.36-2.28, P=0.844) for patients with eGFRs of 60-89, 30-59 and 15-29 ml min(-1) per 1.73 m(2), respectively, compared with patients with an eGFR >or=90. Clinical albuminuria remained a significant risk factor for stroke, and the adjusted HR compared with normoalbuminuria was 2.40 (1.46-3.95, P=0.001). In conclusion, the association between reduced GFR and stroke events in patients with T2DM is likely to be mediated by albuminuria.

Entities:  

Mesh:

Year:  2009        PMID: 19325564     DOI: 10.1038/hr.2009.30

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  6 in total

1.  Relationship between kidney damage and stroke types in Japanese patients.

Authors:  Kosuke Kudo; Tsuneo Konta; Noriyuki Degawa; Shinjiro Saito; Rei Kondo; Takamasa Kayama; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2012-08       Impact factor: 2.801

Review 2.  Cardiorenal connection in chronic kidney disease.

Authors:  Sadayoshi Ito
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

3.  Proteinuria, but Not eGFR, Predicts Stroke Risk in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort Study.

Authors:  Danielle K Sandsmark; Steven R Messé; Xiaoming Zhang; Jason Roy; Lisa Nessel; Lotuce Lee Hamm; Jiang He; Edward J Horwitz; Bernard G Jaar; Radhakrishna R Kallem; John W Kusek; Emile R Mohler; Anna Porter; Stephen L Seliger; Stephen M Sozio; Raymond R Townsend; Harold I Feldman; Scott E Kasner
Journal:  Stroke       Date:  2015-06-30       Impact factor: 7.914

4.  Decreased glomerular filtration rate is associated with mortality and cardiovascular events in patients with hypertension: a prospective study.

Authors:  Rui Zhang; Liqiang Zheng; Zhaoqing Sun; Xingang Zhang; Jue Li; Dayi Hu; Yingxian Sun
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

5.  Arterial stiffness is associated with incident albuminuria and decreased glomerular filtration rate in type 2 diabetic patients.

Authors:  Ryotaro Bouchi; Tetsuya Babazono; Michino Mugishima; Naoshi Yoshida; Izumi Nyumura; Kiwako Toya; Ko Hanai; Nobue Tanaka; Akiko Ishii; Yasuko Uchigata; Yasuhiko Iwamoto
Journal:  Diabetes Care       Date:  2011-10-04       Impact factor: 19.112

6.  Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA).

Authors:  Anthony Pease; Arul Earnest; Sanjeeva Ranasinha; Natalie Nanayakkara; Danny Liew; Natalie Wischer; Sofianos Andrikopoulos; Sophia Zoungas
Journal:  Cardiovasc Diabetol       Date:  2018-06-02       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.